Phytohealth Corp

PhytoHealth Corporation researches, develops, manufactures, and sells medicines, cosmetics, Class B medicines, complementary foods, and related products in Taiwan. It operates in three segments: Medicines and Health Food, Medical Diagnosis, and Precision Medical Equipment and Instruments. The Medicines and Health Food segment manufactures and sells Chinese medicine materials and new drugs, while the Medical Diagnosis segment develops and sells smart medical imaging diagnostic products. The Precision Medical Equipment and Instruments segment researches, develops, manufactures, and sells ultrasound probes and analysis systems. Its pipeline includes PHN031 and PHN033, both in Phase II trials for osteoporosis and diabetic nephropathy, respectively; PHN016 in Phase II for cancer; and PHN017 in Phase I for severe infection-induced cytokine storm. The company also offers PG2 Lyophilized Injection for cancer-related fatigue and capsules for acute moderate to severe pain. Incorporated in 1998, PhytoHealth is based in Taipei, Taiwan.